You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 25, 2024

Litigation Details for Salix Pharmaceuticals Ltd. v. Sun Pharmaceuticals Industries Ltd. (D. Del. 2019)

✉ Email this page to a colleague

« Back to Dashboard

Salix Pharmaceuticals Ltd. v. Sun Pharmaceuticals Industries Ltd. (D. Del. 2019)

Docket	⤷ Sign Up	Date Filed	2019-04-24
Court	District Court, D. Delaware	Date Terminated	2020-09-25
Cause	35:271 Patent Infringement	Assigned To	Richard Gibson Andrews
Jury Demand	Both	Referred To
Parties	SALIX PHARMACEUTICALS LTD.
Patents	10,314,828; 10,335,397; 10,456,384; 7,045,620; 7,612,199; 7,902,206; 7,906,542; 7,915,275; 7,928,115; 8,158,644; 8,158,781; 8,193,196; 8,309,569; 8,518,949; 8,642,573; 8,741,904; 8,829,017; 8,835,452; 8,853,231; 8,946,252; 8,969,398; 9,271,968; 9,421,195; 9,629,828
Attorneys	Elizabeth E. Grden
Firms	Heyman Enerio Gattuso & Hirzel LLP
Link to Docket	External link to docket

Small Molecule Drugs cited in Salix Pharmaceuticals Ltd. v. Sun Pharmaceuticals Industries Ltd.

The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .

Details for Salix Pharmaceuticals Ltd. v. Sun Pharmaceuticals Industries Ltd. (D. Del. 2019)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2020-03-26	1	Complaint	United States Patent Nos. 7,045,620 (the “’620 patent”); 7,612,199 (the “’199 patent”); 7,902,206 (the…infringed one or more claims of United States Patent Nos. 7,045,620; 7,612,199; 7,902,206; 7,906,542; 8,158,644…infringe one or more claims of United States Patent Nos. 7,045,620; 7,612,199; 7,902,206; 7,906,542; 8,158,… C. A judgment that United States Patent Nos. 7,045,620; 7,612,199; 7,902,206; 7,906,542; 8,158,644…to the expiration date of United States Patent Nos. 7,045,620; 7,612,199; 7,902,206; 7,906,542; 8,158,644	External link to document
2021-08-03	118		the Invalidity of U.S. Patent Nos. 8,642,573; 8,969,398; 9,421,195; 10,335,397; and 10,709,694 4. Opening…Bergstrom, Ph.D. Regarding the Invalidity of U.S. Patent No. 7,906,542 2. Opening Expert of Michael J. Zaworotko…Zaworotko, Ph.D. Regarding the Invalidity of U.S. Patent Nos. 7,045,620; 7,612,199; 7,902,206; and 7,906,542… 25 September 2020 1:19-cv-00734 835 Patent - Abbreviated New Drug Application(ANDA) Both	External link to document
2021-10-19	138		Ph.D. Regarding the Invalidity of U.S. Patent Nos. 7,045,620; 7,612,199; 7,902,206; and 7,906,542 (3)…Bergstrom, Ph.D. Regarding the Invalidity of U.S. Patent No. 7,906,542 (7) Responsive Expert Report of Richard…Regarding Noninfringement of Claims 9 and 10 of U.S. Patent No. 7,906,542 filed by Norwich Pharmaceuticals … 25 September 2020 1:19-cv-00734 835 Patent - Abbreviated New Drug Application(ANDA) Both	External link to document
2020-03-26	4	Patent/Trademark Report to Commissioner of Patents	the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,045,620 ;7,612,199 ;7,902,206… 25 September 2020 1:19-cv-00734 835 Patent - Abbreviated New Drug Application(ANDA) Both	External link to document
2020-11-12	60	Appendix	the Commissioner of Patents and Trademarks for Patent/Trademark Number(s): 7,045,620; 7,612,199; 7,902,… 25 September 2020 1:19-cv-00734 835 Patent - Abbreviated New Drug Application(ANDA) Both	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.